Autologous Cytokine-Induced Killer Cells in the Treatment of Multiple Myeloma Concomitant with Lung Cancer and Paraneoplastic Dermatoses-Reference-Cited by-同舟云学术

Autologous Cytokine-Induced Killer Cells in the Treatment of Multiple Myeloma Concomitant with Lung Cancer and Paraneoplastic Dermatoses

Published:2010 Issue:21 Volume:49 Page:2341-2346
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Lin Jie¹,Zhu Hongli¹,Lu Xuechun¹,Yang Bo¹,Han Weidong²,Dai Hanren²,Wang Yao²

Affiliation:

1. Department of Geriatric Hematology, Chinese People's Liberation Army General Hospital

2. Department of Molecular Biology, Institute of Basic Medicine, Chinese People's Liberation Army General Hospital

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/49/21/49_21_2341/_pdf

Reference21 articles.

1. 3. Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153: 1687-1696, 1994.

2. Expansion of Philadelphia Chromosome–Negative CD3+CD56+ Cytotoxic Cells From Chronic Myeloid Leukemia Patients: In Vitro and In Vivo Efficacy in Severe Combined Immunodeficiency Disease Mice

3. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway;Clinical & Translational Immunology;2024-01

2. Simultaneous multiple myeloma and non‑small cell lung carcinoma: A case report and review of the literature;Oncology Letters;2022-05-03

3. Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma;Medicine;2017-01

4. Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study;Biomedicine & Pharmacotherapy;2016-12

5. Impact of Cellular Immune Function on Prognosis of Lung Cancer Patients after Cytokine-induced Killer Cell Therapy;Asian Pacific Journal of Cancer Prevention;2014-08-15